C5a/C5aR1 signaling also exacerbates CRC progression by recruiting myeloid-derived suppressor cells that suppress CD8+ T cell activity in preclinical models (112) and by stabilizing β-catenin in epithelial cells via altered ubiquitination (113). This evidence concerns the gene C5 and colorectal carcinoma.